Position in ABBV
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$22,591,773
-$847,873 QoQ
Shares Held
103,875
+1.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Parallel Advisors, LLC holds $104,513,791 across 18 Drug Manufacturers - General names. ABBV ranks #2 (21.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
30,405 | $27,965,606 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
103,875 | $22,591,773 | |
| 3 | JNJ |
Johnson & Johnson
|
80,406 | $19,654,442 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
75,984 | $10,589,890 | |
| 5 | MRK |
Merck & Co., Inc.
|
56,169 | $6,756,569 | |
| 6 | PFE |
Pfizer Inc
|
129,199 | $3,627,907 | |
| 7 | AMGN |
Amgen Inc
|
10,183 | $3,582,888 | |
| 8 | NVS |
Novartis AG
|
16,366 | $2,499,906 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,591,773 | 103,875 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $23,439,646 | 102,585 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $24,361,018 | 105,213 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $19,418,450 | 104,614 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $22,427,439 | 107,042 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $19,224,474 | 108,185 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $21,486,811 | 108,805 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $18,885,552 | 110,107 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $20,294,498 | 111,447 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $17,109,307 | 110,404 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $16,718,420 | 112,159 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $14,887,665 | 110,500 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $17,819,956 | 111,815 | Shares | Sole | 2024-05-20 | |
| 2022-12-31 | $5,931,733 | 36,704 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $4,482,211 | 33,397 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $4,726,517 | 30,860 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $5,070,800 | 31,280 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $4,278,910 | 31,602 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $3,056,927 | 28,339 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $3,171,041 | 28,152 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $2,707,123 | 25,015 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $2,542,455 | 23,728 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $2,214,012 | 25,277 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $2,402,660 | 24,472 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $1,725,322 | 22,645 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||